Titre : Rites funéraires

Rites funéraires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Trientine

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment identifier un rite funéraire spécifique ?

L'identification se fait par l'analyse des symboles, des pratiques et des croyances culturelles.
Rites funéraires Culture
#2

Quels éléments caractérisent un rite funéraire ?

Les éléments incluent les rituels, les prières, les offrandes et les cérémonies d'enterrement.
Rites funéraires Cérémonies

Symptômes 2

#1

Quels sentiments peuvent émerger lors d'un rite funéraire ?

Les participants peuvent ressentir de la tristesse, de la colère, de la paix ou de la nostalgie.
Émotions Rites funéraires
#2

Comment le deuil se manifeste-t-il pendant un rite ?

Le deuil peut se manifester par des pleurs, des cris ou des comportements de commémoration.
Deuil Rites funéraires

Prévention 2

#1

Comment préparer un rite funéraire à l'avance ?

Il est conseillé de discuter des souhaits avec la famille et de rédiger des directives claires.
Planification Rites funéraires
#2

Quels documents sont nécessaires pour un rite funéraire ?

Les documents incluent le certificat de décès et les arrangements préalables si existants.
Documents légaux Rites funéraires

Traitements 2

#1

Quels soutiens psychologiques sont offerts lors des rites ?

Des conseillers ou des thérapeutes peuvent être présents pour aider les endeuillés.
Soutien psychologique Rites funéraires
#2

Comment les rites funéraires aident-ils au processus de deuil ?

Ils offrent un cadre pour exprimer la douleur et favoriser la mémoire du défunt.
Deuil Rites funéraires

Complications 2

#1

Quelles complications peuvent survenir lors d'un rite ?

Des conflits familiaux ou des désaccords sur les rituels peuvent survenir.
Conflits familiaux Rites funéraires
#2

Comment gérer les émotions intenses lors d'un rite ?

Il est important d'avoir un soutien émotionnel et de permettre l'expression des sentiments.
Soutien émotionnel Rites funéraires

Facteurs de risque 2

#1

Quels facteurs influencent les rites funéraires ?

Les facteurs incluent la culture, la religion, et les traditions familiales.
Culture Rites funéraires
#2

Comment le contexte social affecte-t-il les rites ?

Le contexte social peut déterminer la manière dont les rites sont perçus et pratiqués.
Contexte social Rites funéraires
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Rites funéraires : Questions médicales les plus fréquentes", "headline": "Rites funéraires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Rites funéraires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-27", "dateModified": "2025-03-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Rites funéraires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anthropologie culturelle", "url": "https://questionsmedicales.fr/mesh/D000884", "about": { "@type": "MedicalCondition", "name": "Anthropologie culturelle", "code": { "@type": "MedicalCode", "code": "D000884", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Funérailles", "alternateName": "Burial", "url": "https://questionsmedicales.fr/mesh/D002048", "about": { "@type": "MedicalCondition", "name": "Funérailles", "code": { "@type": "MedicalCode", "code": "D002048", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.150" } } }, { "@type": "MedicalWebPage", "name": "Crémation", "alternateName": "Cremation", "url": "https://questionsmedicales.fr/mesh/D055700", "about": { "@type": "MedicalCondition", "name": "Crémation", "code": { "@type": "MedicalCode", "code": "D055700", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.175" } } }, { "@type": "MedicalWebPage", "name": "Embaumement", "alternateName": "Embalming", "url": "https://questionsmedicales.fr/mesh/D004615", "about": { "@type": "MedicalCondition", "name": "Embaumement", "code": { "@type": "MedicalCode", "code": "D004615", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.250" } } } ], "about": { "@type": "MedicalCondition", "name": "Rites funéraires", "alternateName": "Funeral Rites", "code": { "@type": "MedicalCode", "code": "D005655", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Megumi Kondo-Arita", "url": "https://questionsmedicales.fr/author/Megumi%20Kondo-Arita", "affiliation": { "@type": "Organization", "name": "President's Office, Global Center of Osaka Medical and Pharmaceutical University, Takatsuki, Japan." } }, { "@type": "Person", "name": "Carl B Becker", "url": "https://questionsmedicales.fr/author/Carl%20B%20Becker", "affiliation": { "@type": "Organization", "name": "Policy Science Unit, School of Medicine, Kyoto University, Kyoto, Japan." } }, { "@type": "Person", "name": "Livia Sani", "url": "https://questionsmedicales.fr/author/Livia%20Sani", "affiliation": { "@type": "Organization", "name": "SULISOM UR 3071, Université de Strasbourg, France." } }, { "@type": "Person", "name": "Marie-Frédérique Bacqué", "url": "https://questionsmedicales.fr/author/Marie-Fr%C3%A9d%C3%A9rique%20Bacqu%C3%A9", "affiliation": { "@type": "Organization", "name": "SULISOM UR 3071, Université de Strasbourg, France." } }, { "@type": "Person", "name": "Yozo Taniyama", "url": "https://questionsmedicales.fr/author/Yozo%20Taniyama", "affiliation": { "@type": "Organization", "name": "Department of Religious Studies, Tohoku University, Sendai 980-8576, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.", "datePublished": "2023-07-12", "url": "https://questionsmedicales.fr/article/37137675", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/heartjnl-2022-322271" } }, { "@type": "ScholarlyArticle", "name": "Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients.", "datePublished": "2024-07-09", "url": "https://questionsmedicales.fr/article/38982450", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13023-024-03271-1" } }, { "@type": "ScholarlyArticle", "name": "Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36331262", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jgh.16050" } }, { "@type": "ScholarlyArticle", "name": "Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.", "datePublished": "2022-09-30", "url": "https://questionsmedicales.fr/article/36183738", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2468-1253(22)00270-9" } }, { "@type": "ScholarlyArticle", "name": "Trientine Tetrahydrochloride, From Bench to Bedside: A Narrative Review.", "datePublished": "2024-10-17", "url": "https://questionsmedicales.fr/article/39420162", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40265-024-02099-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences sociales", "item": "https://questionsmedicales.fr/mesh/D012942" }, { "@type": "ListItem", "position": 3, "name": "Anthropologie", "item": "https://questionsmedicales.fr/mesh/D000883" }, { "@type": "ListItem", "position": 4, "name": "Anthropologie culturelle", "item": "https://questionsmedicales.fr/mesh/D000884" }, { "@type": "ListItem", "position": 5, "name": "Rites funéraires", "item": "https://questionsmedicales.fr/mesh/D005655" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Rites funéraires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Rites funéraires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Rites funéraires", "description": "Comment identifier un rite funéraire spécifique ?\nQuels éléments caractérisent un rite funéraire ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Trientine#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Rites funéraires", "description": "Quels sentiments peuvent émerger lors d'un rite funéraire ?\nComment le deuil se manifeste-t-il pendant un rite ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Trientine#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Rites funéraires", "description": "Comment préparer un rite funéraire à l'avance ?\nQuels documents sont nécessaires pour un rite funéraire ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Trientine#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Rites funéraires", "description": "Quels soutiens psychologiques sont offerts lors des rites ?\nComment les rites funéraires aident-ils au processus de deuil ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Trientine#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Rites funéraires", "description": "Quelles complications peuvent survenir lors d'un rite ?\nComment gérer les émotions intenses lors d'un rite ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Trientine#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Rites funéraires", "description": "Quels facteurs influencent les rites funéraires ?\nComment le contexte social affecte-t-il les rites ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Trientine#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un rite funéraire spécifique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par l'analyse des symboles, des pratiques et des croyances culturelles." } }, { "@type": "Question", "name": "Quels éléments caractérisent un rite funéraire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les éléments incluent les rituels, les prières, les offrandes et les cérémonies d'enterrement." } }, { "@type": "Question", "name": "Quels sentiments peuvent émerger lors d'un rite funéraire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les participants peuvent ressentir de la tristesse, de la colère, de la paix ou de la nostalgie." } }, { "@type": "Question", "name": "Comment le deuil se manifeste-t-il pendant un rite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le deuil peut se manifester par des pleurs, des cris ou des comportements de commémoration." } }, { "@type": "Question", "name": "Comment préparer un rite funéraire à l'avance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de discuter des souhaits avec la famille et de rédiger des directives claires." } }, { "@type": "Question", "name": "Quels documents sont nécessaires pour un rite funéraire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les documents incluent le certificat de décès et les arrangements préalables si existants." } }, { "@type": "Question", "name": "Quels soutiens psychologiques sont offerts lors des rites ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des conseillers ou des thérapeutes peuvent être présents pour aider les endeuillés." } }, { "@type": "Question", "name": "Comment les rites funéraires aident-ils au processus de deuil ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils offrent un cadre pour exprimer la douleur et favoriser la mémoire du défunt." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors d'un rite ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits familiaux ou des désaccords sur les rituels peuvent survenir." } }, { "@type": "Question", "name": "Comment gérer les émotions intenses lors d'un rite ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il est important d'avoir un soutien émotionnel et de permettre l'expression des sentiments." } }, { "@type": "Question", "name": "Quels facteurs influencent les rites funéraires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la culture, la religion, et les traditions familiales." } }, { "@type": "Question", "name": "Comment le contexte social affecte-t-il les rites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le contexte social peut déterminer la manière dont les rites sont perçus et pratiqués." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 24/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Megumi Kondo-Arita

4 publications dans cette catégorie

Affiliations :
  • President's Office, Global Center of Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Livia Sani

3 publications dans cette catégorie

Affiliations :
  • SULISOM UR 3071, Université de Strasbourg, France.

Marie-Frédérique Bacqué

3 publications dans cette catégorie

Affiliations :
  • SULISOM UR 3071, Université de Strasbourg, France.

Yozo Taniyama

3 publications dans cette catégorie

Affiliations :
  • Department of Religious Studies, Tohoku University, Sendai 980-8576, Japan.

Shinya Yamada

3 publications dans cette catégorie

Affiliations :
  • National Museum of Japanese History, Sakura 285-8502, Japan.

Kayoko Yamamoto

3 publications dans cette catégorie

Affiliations :
  • Department of Nursing, Tenri Health Care University, Tenri 632-0018, Japan.

Jacques Cherblanc

2 publications dans cette catégorie

Affiliations :
  • Human and Social Sciences, Université du Québec à Chicoutimi(UQAC), Saguenay, Canada.
Publications dans "Rites funéraires" :

Donna M Wilson

2 publications dans cette catégorie

Affiliations :
  • Registered Nurse, Professor, Faculty of Nursing, University of Alberta, Canada.
Publications dans "Rites funéraires" :

Suzanne Rainsford

2 publications dans cette catégorie

Affiliations :
  • Rural Clinical School, Australian National University Medical School, Australia.
Publications dans "Rites funéraires" :

Bruce Rumbold

2 publications dans cette catégorie

Affiliations :
  • Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.

Jennifer Lowe

2 publications dans cette catégorie

Affiliations :
  • Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.

Samar M Aoun

2 publications dans cette catégorie

Affiliations :
  • Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
  • The Perron Institute for Neurological and Translational Science, Perth, Australia.

Iñigo Lorenzo Ruiz

2 publications dans cette catégorie

Affiliations :
  • Nursing Department, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU,Sarriena, Leioa, Spain.
  • BioCruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Selom Komlan Noussoukpoe

2 publications dans cette catégorie

Affiliations :
  • Equipe de recherché de l'Association Togolaise pour le Bien-Etre Familial (ATBEF).

Willis Gwenzi

2 publications dans cette catégorie

Affiliations :
  • Biosystems and Environmental Engineering Research Group, Department of Soil Science and Agricultural Engineering, Faculty of Agriculture, University of Zimbabwe, P.O. Box MP167, Mount Pleasant, Harare, Zimbabwe. Electronic address: wgwenzi@agric.uz.ac.zw.

Noriko Sasaki

2 publications dans cette catégorie

Affiliations :
  • Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.

Veronica E Galimberti

1 publication dans cette catégorie

Affiliations :
  • Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
  • Department of Neurology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :

Carla V Rothlin

1 publication dans cette catégorie

Affiliations :
  • Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :

Sourav Ghosh

1 publication dans cette catégorie

Affiliations :
  • Department of Neurology, Yale University School of Medicine, New Haven, CT.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :

Sources (25 au total)

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.

Hypertrophic cardiomyopathy (HCM) is characterised by left ventricular hypertrophy (LVH), myocardial fibrosis, enhanced oxidative stress and energy depletion. Unbound/loosely bound tissue copper II io... The Efficacy and Mechanism of Trientine in Patients with Hypertrophic Cardiomyopathy (TEMPEST) trial is a multicentre, double-blind, parallel group, 1:1 randomised, placebo-controlled phase II trial d... TEMPEST will determine the efficacy and mechanism of action of trientine in patients with HCM.... NCT04706429 and ISRCTN57145331....

Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients.

Wilson disease (WD) is a rare genetic disease affecting copper metabolism and the biliary tract's copper excretion. Lifelong medication is necessary to prevent liver failure, neurological complication... Ninety out of 92 patients were included in the analysis, excluding two patients who underwent liver transplantation without drug treatment due to an acute liver failure diagnosis. Treatment outcomes a... The median age at diagnosis was 8.3 years. There was a statistically significant difference in drug changes due to treatment ineffectiveness among the three drugs: trientine (22/50, 44%), zinc (15/61,... In pediatric WD, DPA, zinc, and trientine have therapeutic effects in that order. However, DPA and zinc are associated with more adverse effects compared to trientine....

Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl.

This retrospective, multicenter study aims to assess the efficacy and safety in Wilson disease (WD) patients treated with trientine tetrahydrochloride (TETA 4HCl) after switch from trientine dihydroch... In total, 68 WD patients with stable copper metabolism were identified to receive TETA 4HCl (Cuprior™) after previous treatment with TETA 2HCl. We analyzed biochemical markers such as urinary copper, ... The study cohort reflects a common WD cohort with a mean age of 20.3 years at diagnosis and 38.3 years at baseline. There are no significant differences concerning serum copper, NCC, transaminases, AP... Copper parameters and liver function were stable after treatment switch to TETA 4HCl. Treatment with TETA 4HCl was generally well tolerated. This study indicates that the switch from TETA 2HCl to TETA...

Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.

Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-establish copper balance, trientine is indicated for patients with penicillamine intole... We conducted a randomised, open-label, non-inferiority, phase 3 trial at 15 health-care centres across nine countries (patients were recruited from 13 of these health-care centres across Brazil, Europ... Between June 4, 2018, and March 10, 2020, 77 patients were screened. 53 patients were randomly assigned (27 to the penicillamine group and 26 to the TETA4 group). After 24 weeks, the mean difference i... The efficacy of TETA4 as oral maintenance therapy was non-inferior to penicillamine and well tolerated in adults with Wilson disease.... Orphalan....

Efficacy and Safety of Two Salts of Trientine in the Treatment of Wilson's Disease.

Wilson's disease (WD) is one of the few genetic disorders that can be successfully treated with pharmacological agents. Copper-chelating agents (D-penicillamine and Trientine salts) and zinc salts hav... This retrospective cohort study was conducted by reviewing data from the national WD registry in France. Forty-three WD patients who received TETA 2HCL or TETA 4HCL monotherapy for at least one year u... Changes in medication were common, leading to the analysis of 57 treatment sequences of TETA 4HCL or TETA 2HCL. The mean duration of treatment sequence was significantly longer in the TETA 4 HCL group... The two salts of trientine were effective in treating patients with WD. However, interruption of TETA 2HCL was frequent, linked to the cold storage requirement. As adherence to treatment is a key fact...

Biotransformation of triterpenoid ganoderic acids from exogenous diterpene dihydrotanshinone I in the cultures of Ganoderma sessile.

Triterpenoids have shown a wide range of biological activities including antitumor and antiviral effects. Typically, triterpenes are synthesized through the mevalonate pathway and are extracted from n... Firstly, the biotransformation products, two rare GAs were isolated and purified by column chromatography, and characterized using HR-ESI-MS spectrometry and NMR spectrometry. The two compounds were L... Two rare GAs were obtained and characterized. A biosynthetic pathway of GAs from DHT was proposed. Although the synthetic route was not confirmed, this study provided important insights into omics res...